Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK1 in Advanced Breast Cancer
NCT00003165Phase 2Unknown
- Sponsor
- University of Glasgow
- Start
- Dec 1997
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin-HPMA conjugate in breast cancer, sponsored by University of Glasgow. Status: unknown.
02
Drugs
doxorubicin-HPMA conjugate
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003165.